BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8341859)

  • 1. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilator effect of the association ipratropium bromide plus fenoterol (low doses) versus terbutaline and salbutamol in bronchitic patients.
    Marín J; Servera E; Vergara P; Diaz J; Calpe JL; Pérez D; Garcia Barbal J
    Respiration; 1986; 50 Suppl 2():276-9. PubMed ID: 2951821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
    Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
    Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
    Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol.
    Tang OT; Flatley M
    Postgrad Med J; 1984; 60 Suppl 1():24-7. PubMed ID: 6233547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
    Barros MJ; Rees PJ
    Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 13. A dose response study comparing Duovent vs salbutamol.
    Stewart DE; Gillies AJ
    N Z Med J; 1987 Dec; 100(837):742-4. PubMed ID: 2967936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
    Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
    Kaik G
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Berodual and salbutamol in asthma: a multicenter evaluation.
    Philip-Joet F; Reynaud-Gaubert M; Jirou-Najou JL; Arnaud A
    Respiration; 1990; 57(6):379-83. PubMed ID: 2151584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
    Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
    J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.
    McIntosh D
    Pharmatherapeutica; 1986; 4(7):416-21. PubMed ID: 2938194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.